These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening and prevention of breast cancer in primary care. Tice JA, Kerlikowske K. Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154 [Abstract] [Full Text] [Related]
7. The role of magnetic resonance imaging in screening women at high risk of breast cancer. Warner E. Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396 [Abstract] [Full Text] [Related]
11. Improved screening for breast cancer associated with a telephone-based risk assessment. Kadison P, Pelletier EM, Mounib EL, Oppedisano P, Poteat HT. Prev Med; 1998 Jun; 27(3):493-501. PubMed ID: 9612841 [Abstract] [Full Text] [Related]
12. [Breast cancer screening different from that used for the general population: who is concerned and with which approach?]. Chappuis PO. Rev Med Suisse; 2006 May 17; 2(66):1296-8, 1301-2, 1304-5. PubMed ID: 16775990 [Abstract] [Full Text] [Related]
13. Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer. Warner E, Heisey RE, Goel V, Carroll JC, McCready DR. Can Fam Physician; 1999 Jan 17; 45():104-12. PubMed ID: 10889863 [Abstract] [Full Text] [Related]
14. Screening and follow-up of the patient at high risk for breast cancer. Willey SC, Cocilovo C. Obstet Gynecol; 2007 Dec 17; 110(6):1404-16. PubMed ID: 18055740 [Abstract] [Full Text] [Related]
16. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study. Jacobi CE, Nagelkerke NJ, van Houwelingen JH, de Bock GH. Cancer Epidemiol Biomarkers Prev; 2006 Mar 17; 15(3):429-36. PubMed ID: 16537697 [Abstract] [Full Text] [Related]